P.A.W. CAPITAL CORP - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 42 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
P.A.W. CAPITAL CORP ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$295,000
-92.7%
250,000
-53.7%
0.80%
-86.8%
Q3 2022$4,066,000
+19.5%
540,0000.0%6.09%
+23.3%
Q2 2022$3,402,000
-24.1%
540,0000.0%4.94%
+5.5%
Q1 2022$4,482,000
+72.7%
540,000
+8.0%
4.68%
+96.8%
Q4 2021$2,595,000
-2.9%
500,000
+25.0%
2.38%
+0.1%
Q3 2021$2,672,000
-21.6%
400,0000.0%2.38%
-16.9%
Q2 2021$3,408,000
+1.3%
400,000
+5.3%
2.86%
-3.3%
Q1 2021$3,363,000
-31.6%
380,000
-5.0%
2.96%
-31.8%
Q4 2020$4,916,000
+67.8%
400,000
+11.1%
4.34%
+36.0%
Q3 2020$2,930,000
+1.7%
360,000
+20.0%
3.19%
-2.1%
Q2 2020$2,880,000
+17.6%
300,000
-16.7%
3.26%
-1.1%
Q1 2020$2,448,000
+14.1%
360,000
+150.0%
3.30%
+44.0%
Q4 2019$2,146,000
+4.7%
144,000
-28.0%
2.29%
-10.5%
Q3 2019$2,050,000
-3.3%
200,0000.0%2.56%
+11.5%
Q2 2019$2,120,000
-20.2%
200,000
+5.3%
2.29%
-12.7%
Q1 2019$2,656,000
+18.8%
190,000
-13.6%
2.63%
-6.2%
Q4 2018$2,235,000
+432.1%
220,000
+528.6%
2.80%
+528.5%
Q3 2018$420,000
-61.7%
35,000
-61.1%
0.45%
-59.8%
Q2 2018$1,098,000
-17.4%
90,000
-33.3%
1.11%
-30.6%
Q1 2018$1,330,000
-4.7%
135,000
+35.0%
1.60%
-8.9%
Q4 2017$1,395,000
+58.5%
100,000
+25.0%
1.76%
+90.1%
Q3 2017$880,00080,0000.92%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 694,232$8,532,0005.82%
P.A.W. CAPITAL CORP 400,000$4,916,0004.34%
Telemetry Investments, L.L.C. 128,848$1,584,0002.68%
Trellus Management Company, LLC 206,404$2,537,0002.09%
KNOTT DAVID M 295,035$3,626,0001.64%
683 Capital Management, LLC 2,683,600$32,982,0001.56%
INTERWEST VENTURE MANAGEMENT CO 764,918$9,401,0001.17%
TOWERVIEW LLC 130,000$1,598,0001.14%
Vivo Capital, LLC 1,791,257$22,015,0000.98%
Altium Capital Management LP 197,500$2,427,0000.91%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders